# OnCo record zenith-epigenetics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/zenith-epigenetics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "zenith-epigenetics" ;
  schema:name "Zenith Epigenetics"@en ;
  schema:alternateName "Zenith Epigenetics Ltd."@en ;
  schema:description "Zenith Epigenetics is a Calgary biotech whose oral BET inhibitor ZEN-3694 is being tested with enzalutamide in castration-resistant prostate cancer and with PARP inhibitors and immunotherapy in other tumours."@en ;
  schema:url <https://onco.cc/companies/zenith-epigenetics/>, <https://www.zenithepigenetics.com/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.zenithepigenetics.com/> ;
  onco:tag "drug-maker" ;
  schema:addressCountry "CA" ;
  onco:drugs <https://onco.cc/drugs/zen-3694/> .